… in each differential stage, leading to the suppression of tumor growth. Because the …
various tumor-infiltrating lymphocytes, TAMs can serve as targets for cancer immunotherapy…

… differentiation of CSCs. When the cells are committed to differentiation, they cannot initiate
tumor growth … of CD51 could be a therapeutic target for restricting progression of prostate …

… macrophages are not stably differentiated subsets and can … an ideal therapeutic target for
blocking tumor progression after … 4T1 breast cancer growth by modulating TAM differentiation […

… In this review article, we emphasize on the differential expression of integrins structure,
interactions of different motifs or domains, and their function in breast cancer progression. …

… categories of AR therapy resistance: the first … therapy, and the second one involves tumor
progression despite blockade of AR activity. As such AR remains the most attractive drug target …

… In conclusion, the induction of ARMS differentiation by SNAIL silencing leads to the … of
tumor growth, suggesting that SNAIL may be a novel target for differentiation-based therapies in …

… clinically used four SERMS in twenty six cancer cell lines of different origin using Adriamycin
… selected target/ligand with respect to tumor progression, development, treatment responses …

… cancer growth, these cancer stem cells seem to be a likely target for novel strategies for
prostate cancer therapy. … prostate cancer cells caused growth inhibition and rapid apoptosis in …

… associated with cancer transformation and abnormal differentiation of … cancer treatment
strategy. However, for effective destruction of cancer cells initiating and supporting tumor growth …

… promotes cancer stem cell renewal, cell proliferation and differentiation, … target genes provides
a reasonable explanation for how Wnt allows CSC mutations during cancer progression. It …